View Cart

What Anti-Vaccine Policies Could Mean for Autoimmune Diseases

By Giamila Fantuzzi, PhD

Epstein-Barr virus particles (orange): Several studies suggest that EBV plays a role in the etiology of Systemic Lupus Erythematosus and other autoimmune diseases, suggesting the possibility that the condition may be vaccine-preventable. But politics could hinder efforts toward vaccine development (Image: National Institute of Allergy & Infectious Diseases)

(This article originally appeared on Dec. 17, 2025 on www.Undark.org)

Autoimmune diseases disproportionately affect women. This is especially true for lupus (formally known as systemic lupus erythematosus), as about nine in 10 people with the condition are female. Lupus can cause inflammation and pain and commonly affects the skin, joints, and organs including the heart and kidneys.

Scientists have long observed an association between infection with the Epstein-Barr virus, or EBV, and several autoimmune diseases, including lupus. Now, the authors of a study published last month in Science Translational Medicine have dissected that link, shedding light on mechanisms that have remained obscure for too long.

[ ...Read More ]

Featured Articles

Krill Oil Protects Muscle During Intensive Weight Loss

Written by Erik Goldman, Editor

For overweight people, diet-based weight loss interventions are a critical factor in restoring health. But dieting alone without concurrent exercise—which is the reality for many—results in loss of skeletal muscle along with the fat. And that can be very problematic. Some studies indicate that loss of fat-free mass (aka muscle) accounts for between 25%–30% of […]

[ ...Read More ]

Required Reading on GLPs: Ashley Koff’s "Your Best Shot"

Written by Robert Bonakdar, MD, Contributing Writer

GLP-1–based therapies, including glucagon-like peptide-1 receptor agonists (e.g., semaglutide), dual incretin agonists (e.g. tirzepatide), and forthcoming GLP-1–modulating drugs like retatrutide, have rapidly reshaped the clinical management of obesity, type 2 diabetes, and cardiometabolic disease. In less than a decade, these drugs have moved from the weight management and endocrinology niches to much wider use in […]

[ ...Read More ]

HPC Video

Redox, Repair, and Resilience: Breaking the Sympathetic Spiral of Doom with Methylene Blue and GABA Modulation

Written by Erik Goldman

VIEW WEBINAR

Modern life keeps our foot glued to the sympathetic gas pedal—creating a spiral of stress, inflammation, and mitochondrial breakdown. In this free webinar, Dr. Scott Sherr explores how clinicians can break that “Sympathetic Spiral of Doom” by restoring mitochondrial redox balance with methylene blue and rebalancing the nervous system through targeted GABAergic modulation. 

We’ll examine methylene blue as both a redox cycler and mitochondrial rescue agent, reviewing evidence from models of ischemia, infection, and neuroinflammation. You’ll learn clinical indications and practical dosing strategies, as well as the safety considerations that separate high-quality pharma-grade methylene blue from contaminated or subtherapeutic versions commonly found online.

We’ll also connect the dots between mitochondrial dysfunction and GABA deficiency, and show how combining methylene blue with GABA orthosteric and allosteric ligands creates a synergistic, precisely dosed combination that rapidly restores balance between sympathetic overdrive and parasympathetic repair.

VIEW WEBINAR

Sponsored by

[ ...Read More ]

Copyright © 2026 Holistic Primary Care. All Rights Reserved.